DDB2 and malignant colon neoplasm: DDB2 was downregulated in high-grade colon cancer, and low expression of DDB2 inhibited epithelial-to-mesenchymal transition (EMT) of the colon cancer cells, while upregulated the expression of DDB2 inhibited metastasis [12].